These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9367218)

  • 41. Fast liquid chromatography-tandem mass spectrometry method for routine assessment of irinotecan metabolic phenotype.
    Corona G; Elia C; Casetta B; Toffoli G
    Ther Drug Monit; 2010 Oct; 32(5):638-46. PubMed ID: 20683392
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of paclitaxel in human plasma using single solvent extraction prior to isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection.
    Sparreboom A; de Bruijn P; Nooter K; Loos WJ; Stoter G; Verweij J
    J Chromatogr B Biomed Sci Appl; 1998 Jan; 705(1):159-64. PubMed ID: 9498685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma pharmacokinetics of 7-ethyl-10-hydroxycamptothecin (SN-38) after intravenous administration of SN-38 and irinotecan (CPT-11) to rats.
    Kaneda N; Hosokawa Y; Yokokura T; Awazu S
    Biol Pharm Bull; 1997 Sep; 20(9):992-6. PubMed ID: 9331983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of irinotecan and its main metabolites in human plasma and its application in a clinical pharmacokinetic study.
    Marangon E; Posocco B; Mazzega E; Toffoli G
    PLoS One; 2015; 10(2):e0118194. PubMed ID: 25689738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic changes of irinotecan by intestinal alkalinization in an advanced colorectal cancer patient.
    Hamada A; Aoki A; Terazaki H; Ito K; Yokoo K; Sasaki Y; Saito H
    Ther Drug Monit; 2005 Aug; 27(4):536-8. PubMed ID: 16044114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro partition of irinotecan (CPT-11) in human volunteer blood: the influence of concentration, gender and smoking.
    Dumez H; Guetens G; De Boeck G; Highley MS; de Bruijn EA; van Oosterom AT; Maes RA
    Anticancer Drugs; 2005 Sep; 16(8):893-5. PubMed ID: 16096439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of prolonged-release CPT-11-loaded microspheres in rats.
    Machida Y; Onishi H; Kurita A; Hata H; Morikawa A; Machida Y
    J Control Release; 2000 May; 66(2-3):159-75. PubMed ID: 10742577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-Performance liquid chromatographic analysis of lactone and hydroxy acid of new antitumor drug, DX-8951 (exatecan), in mouse plasma.
    Oguma T; Yamada M; Konno T; Inukai K; Nakaoka M
    Biol Pharm Bull; 2001 Feb; 24(2):176-80. PubMed ID: 11217088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of camptothecin analogs in biological matrices by high-performance liquid chromatography.
    Loos WJ; de Bruijn P; Verweij J; Sparreboom A
    Anticancer Drugs; 2000 Jun; 11(5):315-24. PubMed ID: 10912947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis.
    Gasthuys E; van Ovost J; Vande Casteele S; Cosyns S; Ceelen W; Van Bocxlaer J; Vermeulen A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1233():123980. PubMed ID: 38215697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitation of Irinotecan and its two major metabolites using a liquid chromatography-electrospray ionization tandem mass spectrometric.
    Zhang W; Dutschman GE; Li X; Ye M; Cheng YC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3038-44. PubMed ID: 19648066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative determination of liposomal irinotecan and SN-38 concentrations in plasma samples from children with solid tumors: Use of a cryoprotectant solution to enhance liposome stability.
    Nair S; Selvo NS; Stolarski A; Klee B; Federico SM; Stewart CF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Sep; 1245():124273. PubMed ID: 39146822
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical pharmacokinetics of irinotecan and its metabolites: a population analysis.
    Xie R; Mathijssen RH; Sparreboom A; Verweij J; Karlsson MO
    J Clin Oncol; 2002 Aug; 20(15):3293-301. PubMed ID: 12149304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantification of irinotecan, SN38, and SN38G in human and porcine plasma by ultra high-performance liquid chromatography-tandem mass spectrometry and its application to hepatic chemoembolization.
    Chen X; Peer CJ; Alfaro R; Tian T; Spencer SD; Figg WD
    J Pharm Biomed Anal; 2012 Mar; 62():140-8. PubMed ID: 22305081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of column temperature in the high performance liquid chromatographic analysis of topotecan in rat and dog plasma.
    Rosing H; Doyle E; Beijnen JH
    J Pharm Biomed Anal; 1996 Nov; 15(2):279-86. PubMed ID: 8933430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new UPLC-MS/MS method for the determination of irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) in mice: application to plasma and brain pharmacokinetics.
    Goldwirt L; Lemaitre F; Zahr N; Farinotti R; Fernandez C
    J Pharm Biomed Anal; 2012 Jul; 66():325-33. PubMed ID: 22551773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simple non-ion-paired high-performance liquid chromatographic method for simultaneous quantitation of carboxylate and lactone forms of 14 new camptothecin derivatives.
    Sano K; Yoshikawa M; Hayasaka S; Satake K; Ikegami Y; Yoshida H; Ishikawa T; Sawada S; Tanabe S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Sep; 795(1):25-34. PubMed ID: 12957166
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-performance liquid chromatographic analysis of the antitumour drug camptothecin and its lactone ring-opened form in rat plasma.
    Beijnen JH; Rosing H; ten Bokkel Huinink WW; Pinedo HM
    J Chromatogr; 1993 Jul; 617(1):111-7. PubMed ID: 8376523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primates.
    Blaney SM; Takimoto C; Murry DJ; Kuttesch N; McCully C; Cole DE; Godwin K; Balis FM
    Cancer Chemother Pharmacol; 1998; 41(6):464-8. PubMed ID: 9554590
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biliary excretion of irinotecan and its metabolites.
    Itoh T; Takemoto I; Itagaki S; Sasaki K; Hirano T; Iseki K
    J Pharm Pharm Sci; 2004 Jan; 7(1):13-8. PubMed ID: 15144730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.